Moderna to Host Investor Event - Analyst Day
-
Australia skipper Cummins 'good to go' for Adelaide Test
-
Mexico's Sheinbaum holds huge rally following major protests
-
Salah tirade adds to Slot's troubles during Liverpool slump
-
Torres treble helps Barca extend Liga lead, Atletico slip
-
PSG thump Rennes but Lens remain top in France
-
Salah opens door to Liverpool exit with 'thrown under the bus' rant
-
Two eagles lift Straka to World Challenge lead over Scheffler
-
Messi dazzles as Miami beat Vancouver to win MLS title
-
Bielle-Biarrey strikes twice as Bordeaux-Begles win Champions Cup opener in S.Africa
-
Bilbao's Berenguer deals Atletico another Liga defeat
-
Salah opens door to Liverpool exit after being 'thrown under the bus'
-
Bethlehem Christmas tree lit up for first time since Gaza war
-
Slot shows no sign of finding answers to Liverpool slump
-
New Zealand's Robinson wins giant slalom at Mont Tremblant
-
Liverpool slump self-inflicted, says Slot
-
Hundreds in Tunisia protest against government
-
Mofokeng's first goal wins cup final for Orlando Pirates
-
Torres hat-trick helps Barca down Betis to extend Liga lead
-
Bielle-Biarrey strikes twice as Bordeaux win Champions Cup opener in S.Africa
-
Liverpool humbled again by Leeds fightback for 3-3 draw
-
'Democracy has crumbled!': Four arrested in UK Crown Jewels protest
-
Contenders plot path to 2026 World Cup glory as FIFA reveals tournament schedule
-
Inter thump Como to top Serie A ahead of Liverpool visit
-
Maresca fears Chelsea striker Delap faces fresh injury setback
-
Consistency the key to Man City title charge – Guardiola
-
Thauvin on target again as Lens remain top in France
-
Greyness and solitude: French ex-president describes prison stay
-
Frank relieved after Spurs ease pressure on under-fire boss
-
England kick off World Cup bid in Dallas as 2026 schedule confirmed
-
Milei welcomes Argentina's first F-16 fighter jets
-
No breakthrough at 'constructive' Ukraine-US talks
-
Bielle-Biarrey double helps Bordeaux-Begles open Champions Cup defence with Bulls win
-
Verstappen looking for a slice of luck to claim fifth title
-
Kane cameo hat-trick as Bayern blast past Stuttgart
-
King Kohli says 'free in mind' after stellar ODI show
-
Arsenal rocked by Aston Villa, Man City cut gap to two points
-
Crestfallen Hamilton hits new low with Q1 exit
-
Sleepless in Abu Dhabi - nervy times for Norris says Rosberg
-
Arsenal will bounce back from Villa blow: Arteta
-
UN Security Council delegation urges all sides to stick to Lebanon truce
-
Verstappen outguns McLarens to take key pole in Abu Dhabi
-
Syria's Kurds hail 'positive impact' of Turkey peace talks
-
Verstappen takes pole position for season-ending Abu Dhabi GP
-
Jaiswal hits ton as India thrash S. Africa to clinch ODI series
-
UK's Farage rallies in Scottish town hit by immigration protests
-
Saracens kick off European campaign by crushing Clermont
-
Arsenal rocked by Villa as Buendia ends leaders' unbeaten run
-
Venezuela's Machado vows to make Nobel Peace Prize ceremony
-
Kidnapping fears strain family bonds in Nigeria
-
'Chosen' Mbappe on way to making Real Madrid history like Ronaldo: Alonso
NYSE - LSE
| RBGPF | 0% | 78.35 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BP | -3.91% | 35.83 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| BCE | 1.4% | 23.55 | $ |
Moderna to Host Investor Event - Analyst Day
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website
Webcast: investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
N.Mitchell--AT
